← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE; ZIDOVUDINE
NDA · New Drug Application · Sponsor: MYLAN LABS · Approved 2014-02-04
Drug application
- FDA Application #
NDA204914- Application type
- New Drug Application
- Brand name
- LAMIVUDINE; ZIDOVUDINE
- Generic name
- Lamivudine
- Active ingredients
- LAMIVUDINE; ZIDOVUDINE
- Dosage form
- TABLET
- Route
- ORAL SUSPENSION
- Marketing status
- None (Tentative Approval)
- Sponsor
- MYLAN LABS
- First approval
- 2014-02-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown